No death without life: Vital functions of apoptotic effectors

Cell Death and Differentiation

Volumn 15, Issue 7, 2008, Pages 1113-1123

  Galluzzi, L ^a,b,c   Joza, N ^a,b,c   Tasdemir, E ^a,b,c   Maiuri, M C ^a,b,c,d   Hengartner, M ^e   Abrams, J M ^f   Tavernarakis, N ^g   Penninger, J ^h   Madeo, F ⁱ   Kroemer, G ^a,b,c  

^a INSERM   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e UNIVERSITY OF ZURICH   (Switzerland)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g INSTITUTE OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY   (Greece)

^h ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

ⁱ UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; APOPTOSIS INDUCING FACTOR; APOPTOSIS REGULATORY PROTEIN; CASPASE; PROTEIN DERIVATIVE;

AMINO TERMINAL SEQUENCE; APOPTOSIS; AUTOPHAGY; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL FATE; CELL MATURATION; CELL MEMBRANE PERMEABILITY; CELL METABOLISM; CELL STRESS; CELL SURVIVAL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; DNA REPAIR; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE MUTATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOPATHOGENESIS; INNATE IMMUNITY; MAMMAL; MOLECULAR BIOLOGY; MOLECULAR EVOLUTION; NONHUMAN; OXIDATION REDUCTION REACTION; PHENOTYPE; PHYLOGENY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASES; EVOLUTION, MOLECULAR; HUMANS; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MITOCHONDRIAL PROTEINS; SIGNAL TRANSDUCTION;

CAENORHABDITIS ELEGANS; MAMMALIA; NEMATODA; SACCHAROMYCES CEREVISIAE;

EID: 45449097463     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2008.28     Document Type: Review

References (146)

1. Lockshin RA, Williams CM. Programmed Cell Death-I. Cylology Of Degeneration In The Intersegmental Muscles Of The Pernyi Silkmoth. J Insect Physiol 1965; 11: 123-133.
2. Castedo M, Ferri K, Roumier T, Metivier D, Zamzami N, Knoemer G. Quantitation of mitochondrial alterations associated with apoptosis. J Immunol Methods 2002; 265: 39-47.
3. Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeablization in cell death. Physiol Rev 2007; 87: 99-163.
4. Kroemer G, El-Deiry WS, Golstein P, Peter ME, Vaux D, Vandenalbeele P et al. Classification of cell death: Recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ 2005; 12 (Suppl 2): 1463-1467.
5. Galluzzi L, Maiuri MC, Vitale I, Zischka H, Castedo M, Zitvogel L et al. Cell death modalities: Classification and pathophysiological implications. Cell Death Differ 2007; 14: 1237-1243.
6. Horvitz HR. Nobel lecture. Worms, life and death. Biosci Rep 2003; 23: 239-303.
7. Cohen GM. Caspases: The executioners of apoptosis. Biochem J 1997; 326 (Part 1): 1-16.
8. Garrido C, Kroemer G. Life's smile, death's grin: Vital functions of apoptosis-executing proteins. Curr Opin Cell Biol 2004; 16: 639-646.
9. Martinon F, Tschopp J. Inflammatory caspases and inflammasomes: Master switches of inflammation. Cell Death Differ 2007; 14: 10-22.
10. Martinon F, Tschopp J. Inflammatory caspases: Linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004; 117: 561-574.
11. Taylor RC, Cullen SP, Martin SJ. Apoptosis: Controlled demolition at the cellular level. Nat Rev Mol Cell Biol 2008; in press.
12. Marzo I, Susin SA, Petit PX, Ravagnan L, Brenner C, Larochette N et al. Caspases disrupt mitochondrial membrane barrier function. FEBS Lett 1998; 427: 198-202.
13. Zhivotovsky B, Orrenius S. Caspase-2 function in response to DNA damage. Biochem Biophys Res Commun 2005; 331: 859-867.
14. Zhang Y, Padalecki SS, Chaudhuri AR, De Waal E, Goins BA, Grubbs B et al. Caspase-2 deficiency enhances aging-related traits in mice. Mech Ageing Dev 2007; 128: 213-221.
15. Miura M, Chen XD, Allen MR, Bi Y, Gronthos S, Seo BM et al. A crucial role of caspase-3 in osteogenic differentiation of bone marrow stromal stem cells. J Clin Invest 2004; 114: 1704-1713.
16. Weil M, Raff MC, Braga VM. Caspase activation in the terminal differentiation of human epidermal keratinocytes. Curr Biol 1999; 9: 361-364.
17. Wride MA, Parker E, Sanders EJ. Members of the bcl-2 and caspase families regulate nuclear degeneration during chick lens fibre differentiation. Dev Biol 1999; 213: 142-156.
18. Daugas E, Cande C, Kroemer G. Erythrocytes: Death of a mummy. Cell Death Differ 2001; 8: 1131-1133.
19. Zermati Y, Garrido C, Amsellem S, Fishelson S, Bouscary D, Valensi F et al. Caspase activation is required for terminal erythroid differentiation. J Exp Med 2001; 193: 247-254.
20. Ribeil JA, Zermati Y, Vandekerckhove J, Cathelin S, Kersual J, Dussiot M et al. Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1. Nature 2007; 445: 102-105.
21. Krauss SW, Lo AJ, Short SA, Koury MJ, Mohandas N, Chasis JA. Nuclear substructure reorganization during late-stage erythropoiesis is selective and does not involve caspase cleavage of major nuclear substructural proteins. Blood 2005; 106: 2200-2205.
22. Clarke MC, Savill J, Jones DB, Noble BS, Brown SB. Compartmentalized megakaryocyte death generates functional platelets committed to caspase-independent death. J Cell Biol 2003; 160: 577-587.
23. De Botton S, Sabri S, Daugas E, Zermati Y, Guidotti JE, Hermine O et al. Platelet formation is the consequence of caspase activation within megakaryocytes. Blood 2002; 100: 1310-1317.
24. Braun T, Carvalho G, Grosjean J, Ades L, Fabre C, Boehrer S et al. Differentiating megakaryocytes in myelodysplastic syndromes succumb to mitochondrial derangement without caspase activation. Apoptosis 2007; 12: 1101-1108.
25. Sordet O, Rebe C, Plenchette S. Zermati Y, Hermine O, Vainchenker W et al. Specific involvement of caspases in the differentiation of monocytes into macrophages. Blood 2002; 100: 4446-4453.
26. Rebe C, Cathelin S, Launay S, Filomenko R, Prevotat L, L'Ollivier C et al. Caspase-8 prevents sustained activation of NF-kappaB in monocytes undergoing macrophagic differentiation. Blood 2007; 109: 1442-1450.
27. Black S, Kadyrov M, Kaufmann P, Ugele B, Emans N, Huppertz B. Syncytial fusion of human trophoblast depends on caspase 8. Cell Death Differ 2004; 11: 90-98.
28. Chun HJ, Zheng L, Ahmad M, Wang J, Speirs CK. Siegel RM et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 2002; 419: 395-399.
29. Salmena L, Lemmers B, Hakem A, Matysiak-Zablocki E, Murakami K, Au PY et al. Essential role for Caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev 2003; 17: 883-895.
30. Beisner DR, Chu IH, Arechiga AF, Hedrick SM, Walsh CM. The requirements for Fas-associated death domain signaling in mature T cell activation and survival. J Immunol 2003; 171: 247-256.
31. Ben Moshe, Barash H, Kang TB, Kim JC, Kovalenko A, Gross E et al. Role of caspase-8 in hepatocyte response to infection and injury in mice. Hepatology 2007; 45:1014-1024.
32. Kang TB, Ben Moshe T, Varfolomeev EE, Pewzner-Jung Y, Yogev N, Jurewicz A et al. Caspase-8 serves both apoptotic and nonapoptotic roles. J Immunol 2004; 173: 2976-2984.
33. Zhu S, Hsu AP, Vacek MM, Zheng L, Schaffer AA, Dale JK et al. Genetic alterations in caspase- 10 may be causative or protective in autoimmune lymphoproliferative syndrome. Hum Genet 2006; 119 284-294.
34. Shikama Y, Yamada M, Miyashita T. Caspase-8 and caspase-10 activate NF-kappaB through RIP, NIK and IKKalpha kinases. Eur J Immunol 2003: 33: 1998-2006.
35. Wang S, Miura M, Jung YK, Zhu H, Li E, Yuan J. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 1998; 92: 501-509.
36. Li J, Brieher WM, Scimone ML, Kang SJ, Zhu H, Yin H et al. Caspase-11 regulates cell migration by promoting Aip1-Cofilin-mediated actin depolymerization. Nat Cell Biol 2007; 9: 276-286.
37. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 2000; 403: 98-103.
38. Saleh M, Vaillancourt JP, Graham RK, Huyck M, Srinivasula SM, Alnemri ES et al. Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 2004; 429: 75-79.
39. Eckhart L, Declercq W, Ban J, Rendl M, Lengauer B, Mayer C et al. Terminal differentiation of human keratinocytes and stratum corneum formation is associated with caspase-14 activation. J Invest Dermatol 2000; 115: 1148-1151.
40. Denecker G, Hoste E, Gilbert B, Hochepied T, Ovaere P, Lippens S et al. Caspase-14 protects against epidermal UVB photodamage and water loss. Nat Cell Biol 2007; 9: 666-674.
41. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004; 305: 626-629.
42. Ferri KF, Kroemer G. Mitochondria - the suicide organelles. Bioessays 2001; 23: 111-115.
43. Saraste M. Oxidative phosphorylation at the fin de siecle. Science 1999; 283: 1488-1493.
44. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008; 132: 27-42.
45. Galluzzi L, Vicencio JM, Kepp O, Tasdemir E, Maiuri MC, Kroemer G. To die or not to die: That is the autophagic question. Curr Mol Med 2008; in press.
46. Oberstein A, Jeffrey PD, Shi Y. Crystal structure of the Bcl-XL-Beclin 1 peptide complex: Beclin 1 is a novel BH3-only protein. J Biol Chem 2007; 282: 13123-13132.
47. Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005; 122: 927-939.
48. Maiuri MC, Criollo A, Tasdemir E, Vicencio JM, Tajeddine N, Hickman JA et al. BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/ Bcl-X(L). Autophagy 2007; 3: 374-376.
49. Maiuri MC, Le Toumelin G, Criollo A, Rain JC, Gautier F, Juin P et al. Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J 2007: 26: 2527-2539.
50. Abedin MJ, Wang D, McDonnell MA, Lehmann U, Kelekar A. Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ 2007; 14: 500-510.
51. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: Crosstalk between autophaqy and apoptosis. Nat Rev Mol Cell Biol 2007; 8: 741-752.
52. Pinton P, Rizzuto R. Bcl-2 and Ca2+ homeostasis in the endoplasmic reticulum. Cell Death Differ 2006; 13: 1409-1418.
53. Oakes SA, Scorrano L, Opferman JT, Bassik MC, Nishino M, Pozzan T et al. Proapoptotic BAX and BAK regulate the type 1 inositol trisphosphate receptor and calcium leak from the endoplasmic reticulum. Proc Natl Acad Sci USA 2005; 102: 105-110.
54. White C, Li C, Yang J, Petrenko NB, Madesh M, Thompson CB et al. The endoplasmic reticulum gateway to apoptosis by Bcl-X(L) modulation of the InsP3R. Nat Cell Biol 2005; 7: 1021-1028.
55. Dremina ES, Sharov VS, Kumar K, Zaidi A, Michaelis EK, Schoneich C. Anti-apoptotic protein Bcl-2 interacts with and destabilizes the sarcoplasmic/endoplasmic reticulum Ca2+ATPase (SERCA). Biochem J 2004; 383: 361-370.
56. Oakes SA, Opferman JT, Pozzan T, Korsmeyer SJ, Scorrano L. Regulation of endoplasmic reticulum Ca2+ dynamics by proapoptotic BCL-2 family members. Biochem Pharmacol 2003; 66: 1335-1340.
57. Scorrano L, Oakes SA, Opferman JT, Cheng EH, Sorcinelli MD, Pozzan T et al. BAX and BAK regulation of endoplasmic reticulum Ca2+: A control point for apoptosis. Science 2003; 300: 135-139.
58. Demaurex N, Distelhorst C. Cell biology. Apoptosis - The calcium connection. Science 2003; 300: 65-67.
59. Jiao J, Huang X, Feit-Leithman RA, Neve RL, Snider W, Dartt DA et al. Bcl-2 enhances Ca(2+) signaling to support the intrinsic regenerative capacity of CNS axons. EMBO J 2005; 24: 1068-1078.
60. Hoyer-Hansen M, Bastholm L, Szyniarowski P, Campanella M, Szabadkai G, Farkas T et al. Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-beta, and Bcl-2. Mol Cell 2007; 25: 193-205.
61. Perfettini J, Roumier T, Kroemer G. Mitochondrial fusion and fission in the control of apoptosis. Trends Cell Biol 2005; 15: 179-183.
62. Germain M, Mathai JP, McBride HM, Shore GC. Endoplasmic reticulum BIK initiates DRP1-regulated remodelling of mitochondrial cristae during apoptosis. EMBO J 2005; 24: 1546-1556.
63. Wasiak S, Zunino R, McBride HM. Bax/Bak promote sumoylation of DRP1 and its stable association with mitochondria during apoptotic cell death. J Cell Biol 2007; 177: 439-450.
64. Zamzami N, El Hamel C, Maisse C, Brenner C, Munoz-Pinedo C, Belzacq AS et al. Bid acts on the permeability transition pore complex to induce apoptosis. Oncogene 2000; 19: 6342-6350.
65. Kamer I, Sarig R, Zaltsman Y, Niv H, Oberkovitz G, Regev L et al. Proapoptotic BID is an ATM effector in the DNA-damage response. Cell 2005; 122: 593-603.
66. Hosler JP, Ferguson-Miller S, Mills DA. Energy transduction: Proton transfer through the respiratory complexes. Annu Rev Biochem 2006; 75: 165-187.
67. Li K, Li Y, Shelton JM. Richardson JA, Spencer E, Chen ZJ et al. Cytochrome c deficiency causes embryonic lethality and attenuates stress-induced apoptosis. Cell 2000; 101: 389-399.
68. Cain K, Bratton SB, Cohen GM. The Apaf-1 apoptosome: A large caspase-activating complex. Biochimie 2002; 84: 203-214.
69. Garrido C, Galluzzi L, Brunet M, Puig PE, Didelot C, Kroemer G. Mechanisms of cytochrome c release from mitochondria. Cell Death Differ 2006; 13: 1423-1433.
70. Arama E, Agapite J, Steller H. Caspase activity and a specific cytochrome c are required for sperm differentiation in Drosophila. Dev Cell 2003; 4: 687-697.
71. Woo M, Hakem R, Furlonger C, Hakem A, Duncan GS, Sasaki T et al. Caspase-3 regulates cell cycle in B cells: A consequence of substrate specificity. Nat Immunol 2003; 4: 1016-1022.
72. Yang JY, Widmann C. A subset of caspase substrates functions as the Jekyll and Hyde of apoptosis. Eur Cytokine Netw 2002; 13: 404-406.
73. Joza N, Pospisilik JA, Benit P, Rangachari M, Nalkashima Y, Rustin P et al. The molecular archeology of a caspase-independent death effector: AIF in Drosophila. Cell Death Differ 2008; in press.
74. Miramar MD, Costantini P, Ravagnan L, Saraiva LM, Haouzi D, Brothers G et al. NADH oxidase activity of mitochondrial apoptosis-inducing factor. J Biol Chem 2001; 276: 16391-16398.
75. Susin SA, Lorenzo HK, Zamzami N, Matzo I, Snow BE, Brothers GM et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999; 397: 441-446.
76. Modjtahedi N, Giordanetto F, Madeo F, Kroemer G. Apoptosis-inducing factor: Vital and lethal. Trends Cell Biol 2006; 16: 264-272.
77. Cande C, Vahsen N. Kouranti I, Schmitt E, Daugas E, Spahr C et al. AIF and cyclophilin A cooperate in apoptosis-associated chromatinolysis. Oncogene 2004; 23: 1514-1521.
78. Zhu C, Wang X, Deinum J, Huang Z, Gao J, Modjtahedi N et al. Cyclophilin A participates in the nuclear translocation of apoptosis-inducing factor in neurons after cerebral hypoxia-ischemia. J Exp Med 2007; 204: 1741-1748.
79. Cande C. Vahsen N, Metivier D. Tourriere H, Chebli K, Garrido C et al. Regulation of cytoplasmic stress granules by apoptosis-inducing factor. J Cell Sci 2004; 117: 4461-4468.
80. Joza N, Oudit GY, Brown D, Benit P, Kassiri Z, Vahsen N et al. Muscle-specific loss of apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal muscle atrophy. and dilated cardiomyopathy. Mol Cell Biol 2005; 25: 10261-10272.
81. Vahsen N, Cande C, Briere A Benit P, Joza N, Larochette N et al. AIF deficiency compromises oxidative phosphorylation. EMBO J 2004; 23: 4679-4689.
82. Klein JA, Longo-Guess CM, Rossmann MP, Seburn KL, Hurd RE, Frankel WN et al. The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature 2002; 419: 367-374.
83. Pospisilik JA, Knauf C, Joza N, Benit P, Orthofer M, Cani PD et al. Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell 2007; 131: 476-491.
84. Li LY, Luo X, Wang X. Endonuclease G is an apoptotic DNase when released from mitochondda. Nature 2001; 412: 95-99.
85. Huang KJ, Ku CC, Lehman IR. Endonuclease G: A role for the enzyme in recombination and cellular proliferation. Proc Natl Acad Sci USA 2006; 103: 8995-9000.
86. Storchova Z, Breneman A, Cande J, Dunn J, Burbank K, O'Toole E et al. Genome-wide genetic analysis of polyplody in yeast. Nature 2006; 443: 541-547.
87. Buttner S, Carmona-Gutierrez D, Vitale I, Castedo M, Ruli D. Eisenberg T et al. Depletion of endonuclease G selectively kills polyploid cells. Cell Cycle 2007; 6: 1072-1076.
88. Gray CW, Ward RV, Karran E, Turconi S, Rowles A, Viglienghi D et al. Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response. Eur J Biochem 2000; 267 5699-5710.
89. Lipinska B, Zylicz M, Georgopoulos C. The HtrA (DegP) protein, essential for Escherichia coli survival at high temperatures, is an endopeptidase. J Bacteriol 1990; 172: 1791-1797.
90. Verhagen AM, Silke J, Eken PG, Pakusch M, Kaufmann H, Connolly LM et al. HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J Biol Chem 2002; 277: 445-454.
91. Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K, Takahashi R. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell 2001; 8: 613-621.
92. Yang QH, Church-Hajduk R, Ren J, Newton ML, Du C. Omi/HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in apoptosis. Genes Dev 2003; 17: 1487-1496.
93. Vande Walle L, Van Damme P, Lamkanfi M, Saelens X, Vandekerckhove J, Gevaert K et al. Proteome-wide Identification of HtrA2/Omi Substrates. J Proteome Res 2007; 6: 1006-1015.
94. Kuninaka S, Iida SI, Hara T, Nomura M, Naoe H, Morisaki T et al. Serine protease Omi/HtrA2 targets WARTS kinase to control cell proliferation. Oncogene 2007; 26: 2395-2406.
95. Jones JM, Datta P, Srinivasula SM, Ji W, Gupta S, Zhang Z et al. Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice. Nature 2003; 425: 721-727.
96. Martins LM, Morrison A, Klupsch K, Fedele V, Moisoi N, Teismann P et al. Neuroprotective role of the Reaper-related serine protease HtrA2/ Omi revealed by targeted deletion in mice. Mol Cell Biol 2004; 24: 9848-9862.
97. Plun-Favreau H, Klupsch K, Moisoi N, Gandhi S, Kjaer S, Frith D et al. The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat Cell Biol 2007; 9: 1243-1252.
98. Vaux DL, Silke J. HtrA2/Omi, a sheep in wolf's clothing. Cell 2003; 115: 251-253.
99. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 2000; 102: 43-53.
100. Du C, Fang M, Li Y, Li L, Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000; 102: 33-42.
101. Wu G, Chai J, SuberTL, Wu JW, Du C, Wang X et al. Structural basis of IAP recognition by Smac/DIABLO. Nature 2000; 408: 1008-1012.
102. Vaux DL, Silke J. Mammalian mitochondrial IAP binding proteins. Biochem Biophys Res Commun 2003; 304: 499-504.
103. Okada H, Suh WK, Jin J, Woo M, Du C, Elia A et al. Generation and characterization of Smac/DIABLO-deficient mice. Mol Cell Biol 2002; 22: 3509-3517.
104. Jia L, Patwari Y, Kelsey SM, Srinivasula SM, Agrawal SG, Alnemri ES et al. Role of Smac in human leukaemic cell apoptosis and proliferation. Oncogene 2003; 22: 1589-1599.
105. Algeciras-Schimnich A, Shen L, Barnhart BC, Murmann AE, Burkhardt JK, Peter ME. Molecular ordering of the initial signaling events of CD95. Mol Cell Biol 2002; 22: 207-220.
106. Tinel A, Tschopp J. The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 2004; 304: 843-846.
107. Berube C, Boucher LM, Ma W, Wakeham A, Salmena L, Hakem R et al. Apoptosis caused by P53-induced protein with death domain (PIDD) depends on the death adapter protein RAIDD. Proc Natl Acad Sci USA 2005; 102: 14314-14320.
108. Zermati Y, Mouhamad S, Stergiou L, Besse B, Galluzzi L, Boehrer S et al. Nonapoptotic role for apaf-1 in the DNA damage checkpoint. Mol Cell 2007; 28: 624-637.
109. Mouhamad S, Galluzzi L, Zermati Y, Castedo M, Kroemer G. Apaf-1 deficiency causes chromosomal instability. Cell Cycle 2007; 6 3103-3107.
110. Park SM, Schickel R, Peter ME. Nonapoptotic functions of FADD-binding death receptors and their signaling molecules. Curr Opin Cell Biol 2005; 17: 610-616.
111. Yen WC, Pompa JL, McCurrach ME, Shu HB, Elia AJ, Shahinian A et al. FADD: Essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 1998; 279: 1954-1958.
112. Walsh CM, Wen BG, Chinnaiyan AM, O'Rourke K, Dixit VM, Hedrick SM. A role for FADD in T cell activation and development. Immunity 1998; 8: 439-449.
113. Zhang Y, Rosenberg S. Wang H, Imtiyaz HZ, Hou YJ, Zhang J. Conditional Fas-associated death domain protein (FADD): GFP knockout mice reveal FADD is dispensable in thymic development but essential in peripheral T cell homeostasis. J Immunol 2005; 175: 3033-3044.
114. Pellegrini M, Bath S, Marsden VS, Huang DC, Metcalf D, Harris AW et al. FADD and caspase-8 are required for cytokine-induced proliferation of hemopoietic progenitor cells. Blood 2005; 106 1581-1589.
115. Arechiga AF, Bell BD, Leverrier S, Weist BM, Porter M, Wu Z et al. A Fas-associated death domain protein/caspase-8-signaling axis promotes S-phase entry and maintains S6 kinase activity in T cells responding to IL-2. J Immunol 2007; 179: 5291-5300.
116. Sheikh MS, Huang Y. The FADD is going nuclear. Cell Cycle 2003; 2: 346-347.
117. Alappat EC, Feig C, Boyerinas B, Volkland J, Samuels M, Murmann AE et al. Phosphorylation of FADD at serine 194 by CKlalpha regulates its nonapoptotic activities. Mol Cell 2005; 19: 321-332.
118. Balachandran S, Venkataraman T, Fisher PB, Barber GN. Fas-associated death domain-containing protein-mediated antiviral innate immune signaling involves the regulation of Irf7. J Immunol 2007; 178 2429-2439.
119. Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003; 114: 181-190.
120. Zheng L, Bidere N, Staudt D, Culore A. Orenstein J, Chan FK et al. Competitive control of independent programs of tumor necrosis factor receptor-induced cell death by TRADD and RIP1. Mol Cell Biol 2006; 26: 3505-3513.
121. Bender LM, Morgan MJ, Thomas LR, Liu ZG, Thorburn A. The adaptor protein TRADD activates distinct mechanisms of apoptosis from the nucleus and the cytoplasm. Cell Death Differ 2005; 12: 473-481.
122. Janssens S, Tinei A, Lippens S, Tschopp J. PIDD mediates NF-kappaB activation in response to DNA damage. Cell 2005; 123: 1079-1092.
123. Tinel A, Janssens S, Lippens S, Cuenin S, Logette E, Jaccard B et al. Autoproteolysis of PIDD marks the bifurcation between pro-death caspase-2 and pro-survival NF-kappaB pathway. EMBO J 2007; 26 197-208.
124. Cuenin S, Tinel A, Janssens S, Tschopp J. P53-induced protein with a death domain (PIDD) isoforms differentially activate nuclear factor-kappaB and caspase-2 in response to genotoxic stress. Oncogene 2008; 27: 387-396.
125. Felmer R, Horvat S, Clinton M, Clark AJ. Overexpression of Raidd cDNA inhibits differentiation of mouse preadipocytes. Cell Prolif 2003; 36: 45-54.
126. Motaln H, McWhir J, Horvat S. In situ analysis of Raidd-beta-galactosidase fusion gene expression in transgenic mouse midgestation embryos. Transgenic Res 2005; 14: 27-40.
127. Zamzami N, Larochette N, Kroemer G. Mitochondrial permeability transition in apoptosis and necrosis. Cell Death Differ 2005; 12 (Suppl 2): 1478-1480.
128. Brenner C, Grimm S. The permeability transition pore complex in cancer cell death. Oncogene 2006; 25: 4744-4756.
129. Vieira HL, Belzacq AS, Haouzi D, Bernassola F, Cohen I, Jacotot E et al. The adenine nucleotide translocator: A target of nitric oxide, peroxynitrite, and 4-hydroxynonenal. Oncogene 2001; 20: 4305-4316.
130. Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 2005; 434: 652-658.
131. Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA et al. Loss of cyclophilin D reveals a critical role for mitochondirial permeability transition in cell death. Nature 2005; 434: 658:-662.
132. Galluzzi L, Kroemer G. Mitochondrial apoptosis without VDAC. Nat Cell Biol 2007; 9: 487-489.
133. Baines CP, Kaiser RA, Sheiko T, Craigen WJ, Molkentin JD. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol 2007; 9: 550-555.
134. Kokoszka JE, Waymire KG, Levy SE, Sligh JE, Cai J, Jones DP et al. The ADP/ATP translocator is not essential for the mitochondnal permeability transition pore. Nature 2004; 427: 461-465.
135. Belzacq AS, Brenner C. The adenine nucleotide translocator: A new potential chemotherapeutic target. Curr Drug Targets 2003; 4 517-524.
136. Colombini M. Voltage gating in the mitochondrial channel, VDAC. J Membr Biol 1989; 111: 103-111.
137. Gothel SF, Marahiel MA. Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts. Cell Mol Life Sci 1999; 55: 423-436.
138. Schlattner U, Tokarska-Schlattner M, Wallimann T. Mitochondrial creatine kinase in human health and disease. Biochim Biophys Acta 2006; 1762: 164-180.
139. Papadopoulo V. Peripheral benzodiazapine receptor: Structure and function in health and disease. Ann Pharm Fr 2003; 61: 30-50.
140. Wilson JE. Isozymes of mammalian hexokinase: Structure, subcellular localization and metabolic function. J Exp Biol 2003; 206: 2049-2057.
141. Delivani P, Adrain C, Taylor RC, Duriez PJ, Martin SJ. Role for CED-9 and Egl-1 as regulators of mitochondrial fission and fusion dynamics. Mol Cell 2006; 21: 761-773.
142. Wissing S, Ludovico P, Herker E, Buttner S, Engelhardt SM, Decker T et al. An AIF orthologue regulates apoptosis in yeast. J Cell Biol 2004; 166: 969-974.
143. Madeo F, Herker E, Maldener C. Wissing S, Lachelt S, Herlan M et al. A caspase-related protease regulates apoptosis in yeast. Mol Cell 2002; 9: 911-917.
144. Lim HW, Kim SJ, Park EH, Lim CJ. Overexpression of a metacaspase gene stimulates cell growth and stress response in Schizosaccharomyces pombe. Can J Microbiol 2007; 53: 1016-1023.
145. Ambit A, Fasel N, Coombs GH, Mottram JC. An essential role for the Leishmania major metacaspase in cell cycle progression. Cell Death Differ 2008; 15: 113-122.
146. Siegel RM. Caspases at the crossroads of immune-cell life and death. Nat Rev Immunol 2006; 6: 308-317.